Anti-Inflammatory Versus Antifibrotic Therapies for the Management of Rheumatoid Arthritis–Associated Interstitial Lung Disease: Protocol for a Systematic Review and Meta-Analysis
BackgroundRheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that affects approximately 0.5% to 1% of the population in the United States and Northern Europe. Interstitial lung disease (ILD) is the most common and severe pulmonary manifestation of RA, coll...
Saved in:
| Main Authors: | Sneh Sonaiya, Alexandra Jianu, Nicholas Jianu, Kavita Batra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2025-07-01
|
| Series: | JMIR Research Protocols |
| Online Access: | https://www.researchprotocols.org/2025/1/e73219 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INTERSTITIAL LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS
by: David Vladimirovich Bestaev, et al.
Published: (2012-12-01) -
Interstitial lung involvement in rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2014-12-01) -
Interstitial Lung Disease in Rheumatoid Arthritis in the Era of Biologics
by: A. Picchianti Diamanti, et al.
Published: (2011-01-01) -
Interstitial lung disease as an extra-articular manifestation of rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2013-06-01) -
Factors associated with interstitial lung disease in patients with rheumatoid arthritis
by: Benyapa Suppa-Udom, et al.
Published: (2024-09-01)